DOUBLE-HIT LYMPHOMA
Clinical trials for DOUBLE-HIT LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new DOUBLE-HIT LYMPHOMA trials appear
Sign up with your email to follow new studies for DOUBLE-HIT LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail shows promise for Tough-to-Treat lymphomas
Disease control OngoingThis phase 2 trial tests whether adding polatuzumab vedotin to standard chemotherapy can improve outcomes for people with aggressive B-cell lymphomas, including double-hit and triple-hit types. Only 8 participants were enrolled, and the study focuses on safety and how many achiev…
Matched conditions: DOUBLE-HIT LYMPHOMA
Phase: PHASE2 • Sponsor: Barbara Ann Karmanos Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
New drug combo shows promise for tough lymphoma
Disease control OngoingThis study tests adding a drug called selinexor to the standard chemotherapy RCHOP for people with B-cell non-Hodgkin lymphoma. The goal is to find the safest dose and see if the combination works better than standard treatment alone. About 43 adults with advanced or returning ly…
Matched conditions: DOUBLE-HIT LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: Barbara Ann Karmanos Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC